| abstract |
Since the peptide has a simpler structure than the conventional natural human erythropoietin, it can easily pass through the protective membrane of tissues and blood vessels, has an excellent physiological activity in the protective activity of cells, and requires little production cost. Pharmaceutical compositions containing the erythropoietin-derived peptide as an active ingredient, have economic advantages, have no cell proliferation side effects, have stroke, nervous system mechanical or ischemic damage, myocardial infarction, retinal damage and diabetes It is useful for the prevention or treatment of diseases related to cell damage and the like, and for pharmaceutical compositions for preventing cell damage. |